New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development
暂无分享，去创建一个
T. Marlovits | D. Krug | J. Herrmann | A. Hirsch | A. M. Kany | Rolf Müller | Joy Birkelbach | Christoph Porten | Biao Yuan | Carsten E. Seyfert | Alison V. Müller | Danica J. Walsh